Skip to main content
Log in
Adis
Drug Safety

The Official Journal of the International Society of Pharmacovigilance [ISoP]

Publishing model:

Editors

Editor (Adis International Limited, Auckland, New Zealand):

Mr Nitin Joshi, BPharm, PGDipPharm. Adis International Limited, Auckland, New Zealand

Editorial Board:

Professor G. Caleb Alexander, MD MS. John Hopkins School of Public Health, Baltimore, MD, USA

Associate Professor Giuseppe Andò, MD PhD. University of Messina, Messina, Italy

Laurent Azoulay, McGill University, Montreal, QC, Canada

Dr Priya Bahri, PhD. European Medicines Agency, Amsterdam, the Netherlands

Dr Joanne Barnes, BPharm(Hons) PhD FISoP FLS. University of Auckland, Auckland, New Zealand

Dr Andrew Bate. GSK, Brentford, UK

Professor David Bates, MSc MD. Harvard Medical School, Boston, MA, USA

Professor Frank M.C. Besag, MB ChB PhD FRCP FRCPCH FRCPsych. East London Foundation NHS Trust, London, UK

Professor Dr Subhrojyoti Bhowmick, MD FISQUa(UK). KPC Medical College and Hospital, Kolkata, West Bengal, India

Professor Einar Björnsson, MD PhD. University of Iceland, Reykjavik, Iceland

Dr Benjamin Bray, MD. Lane Clark & Peacock, London, UK

Professor Nick Buckley, MD FRACP. University of Sydney, Sydney, NSW, Australia

Professor Anthony R. Cox, BSc(Hons) PhD FBPhS FRPharmS Clin Dip Pharm PGCert FHEA. University of Birmingham, London, UK

Dr Nabarun Dasgupta, MPH PhD. University of North Carolina, Chapel Hill, NC, USA

Professor Richard Day, AM MD FRACP. University of New South Wales, Sydney, Australia

Professor Fabrizio De Ponti, MD. University of Bologna, Bologna, Italy

Alexander Dodoo, University of Ghana Medical School, Accra, Ghana

Professor I. Ralph Edwards, DSc(h.c.) MB ChB MRCS FRCP(Lond) FRACP FRCP(Edin). Gothenburg, Sweden

Professor Dr Toine Egberts, PharmD PhD. Utrecht University & University Medical Center, Utrecht, the Netherlands

Professor Adolfo Figueiras, PhD. University of Santiago de Compostela, Santiago de Compostela, Spain

Dr Joshua Gagne, PharmD ScD. Johnson & Johnson; and Harvard T.H. Chan School of Public Health, Boston, MA, USA

Stephen Goldman, Stephen A Goldman Consulting Services, Morris Plains, NJ, USA

Professor Staffan Hägg, MD PhD. Linköping University, Linköping, Sweden

Dr Kenneth Hartigan-Go, MD(UK) FPCP FRCPE FICD. Ateneo De Manila University, Quezon, Philippines

Professor Laurie Howes, MB BS PhD FRACP FCSANZ. Griffith University, Southport, QLD, Australia

David Hunt, Anne Rowling Clinic and MRC Institute of Genetics and Molecular Medicine, Edinburgh, UK

Professor Susan Jick, DSc. Boston University School of Public Health, Lexington, MA, USA

Stephan Krähenbühl, University Hospital Basel, Basel, Switzerland

Dr Joan-Ramon Laporte, MD. Universitat Autònoma de Barcelona, Barcelona, Spain

Dr Deborah Layton, BSc MPhil MSc DipClinPharm PhD FHEA FRPharmS MScbFISPE. PEPI Consultancy Ltd, Southampton, UK; and University of Hertfordshire, UK

Hervé Le Louet, Takeda, Zurich, Switzerland

Professor James H. Lewis, MD FACP FACG AGAF FAASLD. Georgetown University School of Medicine, Georgetown, DC, USA

Dr David Liew, MBBS FRACP. Austin Health, Heidelberg, VIC, Australia 

Dr Marie Lindquist, MSc PhD Hon FRCP FISoP, Uppsala Monitoring Centre, Gothenburg, Sweden

Professor Yoon Loke, MBBS MD. University of East Anglia, Norwich, UK

Yuan Luo, Northwestern University, Chicago, IL, USA

Professor Dr Christoph Meier, MSc PhD. University of Basel, Basel, Switzerland

Ronald Meijboom, University of Utrecht, Utrecht, the Netherlands

Professor Peter Mol, PharmD PhD. University Medical Center Groningen, Groningen, the Netherlands

Professor Jean-Louis Montastruc, MD PhD. Faculty of Medicine, Toulouse, France

Professor Nicholas Moore, MD PhD, `Emeritus Professor of clinical pharmacology, Universite de Bordeaux, Bordeaux, France

Dr Pantelis Natsiavas, PhD. Centre for Research and Technology Hellas, Thessaloniki, Greece

Dr G. Niklas Norén, MSc Eng PhD. The Uppsala Monitoring Centre, Uppsala, Sweden

Professor Sir Munir Pirmohamed, MB ChB FRCP PhD FBPhS FMedSci. University of Liverpool, Liverpool, UK

Professor Francesco Salvo, MD PhD. Université de Bordeaux, Bordeaux, France

Dr Ruth Savage, MBBS MSc. New Zealand Pharmacovigilance Centre, University of Otago, New Zealand

Professor Nigam Shah, MBBS PhD. Stanford University School of Medicine, Stanford, CA, USA

Dr Rashmi Shah, BSc MBBS MD FRCP FFPM HonFBPhS. Pharmaceutical Consultant, Gerrards Cross, Buckinghamshire, UK

Saad Shakir, Drug Safety Research Unit, Southampton, Hampshire, UK

Professor Emeritus Neil H. Shear, MD. University of Toronto, Toronto, ON, Canada

Dr. Janet Sultana, PhD. Mater Dei Hospital, Msida, Malta

Professor Nicholas Tatonetti, PhD. Columbia University, New York, NY, USA

Professor Gianluca Trifirò, MD PhD FISPE FISOP. University of Verona, Verona, Italy

Dr Marco Tuccori, Pharm D PhD. University Hospital of Pisa, Pisa, Italy

Professor Eugene van Puijenbroek, MD PhD. Netherlands Pharmacovigilance Centre Lareb, 's-Hertogenbosch, the Netherlands

Distinguished Professor Almut G Winterstein, RPh, PhD, FISPE. University of Florida, Gainesville, FL, USA

Ian Wong, UCL School of Pharmacy, London, UK

Li Zhang, Beijing University of Chinese Medicine, Beijing, China

Navigation